Showing results (11-20 of 82) with videos related to
Sort By:
Pageof 9
Expert Opinion on Therapeutic Patents|August 23, 2012
Protein kinase CK2 inhibitors: a patent reviewGiorgio Cozza, Lorenzo A Pinna, Stefano MoroAntioxidants (Basel, Switzerland)|December 30, 2025
Ferroptosis in Human Diseases: Fundamental Roles and Emerging Therapeutic PerspectivesIlaria Artusi, Michela Rubin, Giovanni Cravin, et al.Antioxidants & Redox Signaling|July 24, 2010
A comparison of thiol peroxidase mechanismsLeopold Flohé, Stefano Toppo, Giorgio Cozza, et al.Biomed Research International|November 12, 2015
The Selectivity of CK2 Inhibitor Quinalizarin: A ReevaluationGiorgio Cozza, Andrea Venerando, Stefania Sarno, et al.The FEBS Journal|February 26, 2017
Fam20C is under the control of sphingolipid signaling in human cell linesGiorgio Cozza, Mauro Salvi, Vincent S Tagliabracci, et al.International Journal of Molecular Sciences|April 13, 2023
Monitoring Nrf2/ARE Pathway Activity with a New Zebrafish Reporter SystemLorenzo Badenetti, Rosa Manzoli, Michela Rubin, et al.Anti-Cancer Agents in Medicinal Chemistry|October 6, 2009
ATP non-competitive Ser/Thr kinase inhibitors as potential anticancer agentsGiorgio Cozza, Andrea Bortolato, Ernesto Menta, et al.Physiologia Plantarum|May 28, 2009
A novel splicing variant encoding putative catalytic alpha subunit of maize protein kinase CK2Maja Lebska, Jadwiga Szczegielniak, Grazyna Dobrowolska, et al.Chemmedchem|May 19, 2011
The role of the N-terminal domain in the regulation of the "constitutively active" conformation of protein kinase CK2α: insight from a molecular dynamics investigationAndrea Cristiani, Giorgio Costa, Giorgio Cozza, et al.Plos One|March 4, 2014
Synthesis and properties of a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2)Giorgio Cozza, Sofia Zanin, Renate Determann, et al.Pageof 9